Pharma-Bio Serv (PBSV) Accumulated Depreciation & Amortization (2011 - 2025)
Pharma-Bio Serv posted quarterly Accumulated Depreciation & Amortization of $199929.0 for Q4 2025, down 69.63% year-on-year from $658249.0 in Q4 2024, and down 69.63% on a QoQ basis from $658249.0 in Q4 2024.
Pharma-Bio Serv (PBSV) has 14 years of Accumulated Depreciation & Amortization data on file, last reported at $199929.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 69.63% year-over-year to $199929.0; the trailing twelve-month figure through Oct 2025 stood at $199929.0 (down 69.63% YoY), and the FY2025 full-year result was $199929.0, down 69.63% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $199929.0, down from $658249.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $658249.0 in Q4 2024 and bottomed at $199929.0 in Q4 2025.
- The 5-year median for Accumulated Depreciation & Amortization is $587089.0 (2022), against an average of $523732.0.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization gained 9.05%; it then plunged 69.63% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $538384.0 in 2021, then climbed by 9.05% to $587089.0 in 2022, then rose by 8.16% to $635009.0 in 2023, then climbed by 3.66% to $658249.0 in 2024, then slumped by 69.63% to $199929.0 in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $199929.0 (Q4 2025), $658249.0 (Q4 2024), and $635009.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 199,929.00 |
| Oct 31, 2025 | 199,929.00 |
| Oct 31, 2024 | 658,249.00 |
| Oct 31, 2024 | 658,249.00 |
| Oct 31, 2023 | 635,009.00 |
| Oct 31, 2023 | 635,009.00 |
| Oct 31, 2022 | 587,089.00 |
| Oct 31, 2022 | 587,089.00 |
| Oct 31, 2021 | 538,384.00 |
| Oct 31, 2021 | 538,384.00 |
| Oct 31, 2020 | 501,489.00 |
| Oct 31, 2020 | 501,489.00 |
| Oct 31, 2019 | 509,275.00 |
| Oct 31, 2019 | 509,275.00 |
| Oct 31, 2018 | 496,953.00 |
| Oct 31, 2018 | 496,953.00 |
| Oct 31, 2017 | 455,147.00 |
| Oct 31, 2017 | 455,147.00 |
| Oct 31, 2016 | 1.94 Mn |
| Oct 31, 2016 | 1.94 Mn |
| Oct 31, 2015 | 1.79 Mn |
| Oct 31, 2015 | 1.79 Mn |
| Oct 31, 2013 | 1.88 Mn |
| Oct 31, 2013 | 1.88 Mn |
| Oct 31, 2012 | 321,732.00 |
| Oct 31, 2012 | 321,732.00 |
| Oct 31, 2011 | 320,861.00 |
| Oct 31, 2011 | 320,861.00 |